Jump to Navigation
MDA | Muscular Dystrophy Association
  • About MDA
  • Advocacy
  • Publications
  • Media
Give Now.
Give online Give by mail Give by phone

Main menu

  • Home
  • Learn About Muscle Diseases
  • Help Through Services
  • Hope Through Research
  • Ways to Help MDA

Search form

Research News

[title]
ALS Research: Zenvia Improves Emotional Symptoms in ALS
April 12, 2010
The experimental drug Zenvia, developed by Avanir Pharmaceuticals as a treatment for unwanted laughing/crying spells in ALS, has shown continued promise in lessening the frequency of such episodes
[title]
ALS Research: Zenvia Improves Emotional Symptoms in ALS
April 12, 2010
The experimental drug Zenvia, developed by Avanir Pharmaceuticals as a treatment for unwanted laughing/crying spells in ALS, has shown continued promise in lessening the frequency of such episodes in
[title]
MDA Study Shows Lithium Not Helpful in ALS
April 12, 2010
An MDA-supported, 10-center trial of more than 100 people with amyotrophic lateral sclerosis (ALS) who took the oral medication lithium carbonate — some in conjunction with the ALS drug riluzole —
[title]
MDA Awards Two New FSHD Grants
April 05, 2010
MDA has awarded two grants for research aimed at determining the precise molecular causes of facioscapulohumeral dystrophy (FSHD), and developing therapies for the disease. MDA and Friends of FSH
[title]
Familial ALS Research Update
April 02, 2010
The state of research in the familial (inherited) form of ALS was the focus of a special one-hour Webinar presented by the ALS Therapy Development Institute (ALS TDI) on March 25, with reports by CEO
[title]
Familial ALS Research Update
April 02, 2010
The state of research in the familial (inherited) form of ALS was the focus of a special one-hour Webinar presented by the ALS Therapy Development Institute (ALS TDI) on March 25, with reports by
[title]
ALS Research: Disconnecting the Immune System
March 29, 2010
Blocking a key molecular pathway that the body uses to amplify an immune response has been found to delay disease onset and extend survival in mice with a disease that mimics human amyotrophic
[title]
ALS Research: Disconnecting the Immune System
March 28, 2010
Blocking a key molecular pathway that the body uses to amplify an immune response has been found to delay disease onset and extend survival in mice with a disease that mimics human amyotrophic
[title]
Tadalafil Trial in Becker MD
March 24, 2010
Update (Oct. 8, 2012): This story has been updated to reflect that the tadalafil trial in BMD has been slightly revised and is now open. In June 2012, it had temporarily closed to new participants.
[title]
Gentamicin Trial in DMD Shows Mixed Results
March 23, 2010
An MDA-supported clinical trial of intravenous gentamicin in children and adolescents with a form of Duchenne muscular dystrophy (DMD) caused by so-called "nonsense" mutations (also called "premature
[title]
DMD Research: Potential Heart Saver
March 22, 2010
A synthetic compound that seals cellular membranes has been found to stop the progression of heart-muscle destruction in dogs with a disease closely resembling human Duchenne muscular dystrophy (DMD
[title]
SMA Research: Saving Shortened SMN Protein
March 17, 2010
A research team at the University of Pennsylvania in Philadelphia has characterized the mechanism responsible for rapid decay of the survival of motor neurons (SMN) protein that is encoded by the
[title]
Gene Therapy Book by MDA Grantee
March 08, 2010
MDA grantee Dongsheng Duan has published a book on the latest advances in gene therapy for muscle disease, particularly muscular dystrophies. Duan, a professor of microbiology and immunology at the
[title]
ALS SOD1 Trial: A ‘Watershed Moment’
March 05, 2010
Isis Pharmaceuticals of Carlsbad, Calif., has begun a phase 1 clinical trial of its experimental compound ISIS-SOD1-Rx in people with familial (inherited) ALS caused by toxic SOD1 protein molecules
[title]
ALS SOD1 Trial: A ‘Watershed Moment’
March 05, 2010
Isis Pharmaceuticals of Carlsbad, Calif., has begun a phase 1 clinical trial of its experimental compound ISIS-SOD1-Rx in people with familial (inherited) ALS caused by toxic SOD1 protein molecules
[title]
DMD/BMD Research: Ataluren Results Disappointing
March 03, 2010
The biopharmaceutical firm PTC Therapeutics announced March 3 that ataluren, its experimental drug for certain forms of Duchenne (DMD) and Becker (BMD) muscular dystrophy, although safe and well
[title]
Gene Therapy Rescues Mice with SMA
March 01, 2010
Scientists at four U.S. institutions have successfully used gene therapy to treat very young mice with a disease resembling severe spinal muscular atrophy (SMA).  Study results were published online
[title]
SMA Therapeutics: Changing the Code
February 26, 2010
 A process called trans-splicing has been shown to increase levels of a needed protein in mice with a disease resembling severe human spinal muscular atrophy (SMA), says a research team at the
[title]
A Quicker Trip from ‘Microscope to Marketplace’?
February 26, 2010
The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) have announced plans to establish a Joint NIH-FDA Leadership Council, with the goal of shortening the time it
[title]
Building New Muscle Requires Controlled Damage
February 23, 2010
Remodeling a building usually requires some degree of dismantling before new construction can begin. That principle, it now seems, also may apply to the remodeling of the body's cells.  Scientists at
[title]
SMA Research: Strengthening the Junctions
February 22, 2010
MDA-supported researchers at the University of Ottawa and Ottawa Hospital Research Institute (OHRI) have identified a biological pathway that may prove useful in developing treatments for spinal
[title]
Causative Gene Mutations ID'd for Two Muscle Diseases
February 18, 2010
An MDA-supported, multinational team of researchers from Canada and Europe has identified specific mutations in the anoctamin 5 (ANO5) gene on chromosome 11 that can cause type 2L limb-girdle
[title]
Cardiomyopathy in Becker MD
February 12, 2010
This story was updated Oct. 6, 2010. In many forms of muscular dystrophy, including Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), weakness and degeneration of the cardiac
[title]
New Muscle Stem Cell Found in Mice
February 09, 2010
MDA-supported scientists in France have identified a previously unknown type of muscle stem cell located in the spaces between muscle fibers in mice. They say the new cells, dubbed "PICs," may play
[title]
MMD1: Lost Proteins’ Roles Revealed?
February 02, 2010
Scientists at several U.S. institutions have added yet another piece of the puzzle of type 1 myotonic dystrophy (MMD1, also called DM1). Much of the problem in this disease appears to be caused by

Pages

  • « first
  • ‹ previous
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • next ›
  • last »
View All News

Research

  • Research News
  • Active Research Grants
  • Research Grants Programs
  • MDA Translational Research Program
    • Clinical Research Training Grant (CRTG)
    • Funded Projects
    • MDA Venture Philanthropy
  • Opportunities for Researchers
  • Annual Conference Series
  • Grants at a Glance — Winter 2013
  • MDA Research Contact
  • Helpful Links
  • Clinical Trials and Studies
  • Clinical Research Network Grant
  • Newborn Screening for Neuromuscular Diseases
  • MyoBlast Research Newsletter
    • Volume 1, Issue 1, October 2011
    • Volume 2, Issue 1, February 2012
MDA in Your Community


Quick Links

  • Tell Us About Your MDA Clinic
  • Become an MDA Advocate
  • Be a Summer Camp Volunteer
  • Sign Up for MDA News Updates
  • MDA's Muscle Shop

Give Now.

Ways To Help

  • Advocacy
  • Become a Volunteer
  • Donor Login
  • Legacy Gifts
  • MDA Programs
  • Matching Gifts

About MDA

  • Art Collection
  • Contact MDA
  • Become a Volunteer
  • Careers
  • FAQ
  • Media
  • What is MDA?

MDA.org

  • Find Support
  • Get Involved
  • Publications
  • Site Map
  • Muscle Shop

Connect with MDA

  • Facebook Twitter YouTube  

Muscular Dystrophy Association — USA
National Headquarters
3300 E. Sunrise Drive
Tucson, AZ 85718
(800) 572-1717

Privacy Policy | Terms of Use

©2013, Muscular Dystrophy Association Inc. All rights reserved.
 

Advertise